Total laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 5-6, 2009, Pages 470-475

  Garvey, Christopher M ^a   Boylan, Kevin B ^b   Salassa, John R ^a   Kennelly, Kathleen D ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic Florida   (United States)

Author keywords

Amyotrophic lateral sclerosis; Aspiration; Bulbar symptoms; Laryngectomy; Quality of life

Indexed keywords

STEROID;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AWARENESS; BULBAR PARALYSIS; CAREGIVER; CLINICAL ARTICLE; CONTACT DERMATITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSPHONIA; FEMALE; GRANULATION TISSUE; HOSPITALIZATION; HUMAN; LARYNGECTOMY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATIENT SAFETY; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PHYSICIAN; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SURGICAL RISK; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT INDICATION; UNITED STATES;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; LARYNGECTOMY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70450169428     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960802578373     Document Type: Article

References (26)

1. Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Current Opinion in Neurology & Neurosurgery. 2005;18:487-93.
2. Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Br Med J. 2001;54:386-92.
3. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586-90.
4. Strong MJ. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;1-16. (Epub ahead of print).
5. Murphy J, Henry R, Lomen-Hoerth C. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:330-4.
6. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Reviews Neuroscience. 2006;7:710-23.
7. Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Human Molecular Genetics. 2007;16:R233-42.
8. Simmons Z. Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. The Neurologist. 2005;11:257-70.
9. Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:585-91.
10. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis: a population-based study in Ireland, 1996-2000. J Neurol. 2003;250:473-9. (Pubitemid 36459755)
11. Boylan KB. Amyotrophic Lateral Sclerosis. In: Wszolek Z, editor. Neurology: basic and clinical neurosciences. New York: Elsevier, 2007. p. 859-78.
12. Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59:99-103. (Pubitemid 34742801)
13. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242:695-8.
14. Radunovic A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:913-25. (Pubitemid 47422248)
15. Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:33-40.
16. Simmons Z, Felgoise SH, Bremer BA, Walsh SM, Bromberg MB, David W, et al. Development and validation of an ALSspecific quality of life instrument. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(Suppl 2):140.
17. Neudert C, Wasner M, Borasio GD. Patients' assessment of quality of life instruments: a randomized study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neuro Sci. 2001;191:103-9.
18. Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology. 2001;56:442-4.
19. Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388-92.
20. Gelinas DF, O'Connor P, Miller RG. Quality of life for ventilator-dependent ALS patients and their caregivers. J Neurol Sci. 1998;160(Suppl 1):S134-6.
21. Kaub-Wittemer D, Von Steinbuchel N, Wasner M, Laier-Groenveld G, Borasio GD. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26: 890-6.
22. Goode RL, Smith RA. The surgical management of sialorrhea. Laryngoscope. 1970;80:1078-89.
23. Charchaflie FJ, Fernandez LB, Perec CJ, Gonzalez E, Marzi A. Functional studies of the parotid and pancreas glands in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1974;37:863-7.
24. Woodard TD, Oplatek A, Petruzzelli GJ. Life after total laryngectomy: a measure of long-term survival, function, and quality of life. Arch Otolaryngol Head Neck Surg. 2007;133:526-32.
25. Takano Y, Suga M, Sakamoto O, Sato K, Samejima Y, Ando M. Satisfaction of patients treated surgically for intractable aspiration. Chest. 1999;116:1251-6.
26. Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65: 1774-7.